Paget's Disease of Bone
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
NovartisBASEL, Switzerland
1 programGenetic Study of Families Affected by Paget's Disease of BoneN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
NovartisGenetic Study of Families Affected by Paget's Disease of Bone
Clinical Trials (1)
Total enrollment: 83 patients across 1 trials
Genetic Study of Families Affected by Paget's Disease of Bone
Start: Sep 2007Est. completion: Sep 200883 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space